Body size phenotypes and inflammation in the women's health initiative observational study

Obesity

Volumn 19, Issue 7, 2011, Pages 1482-1491

  Wildman, Rachel P ^a   Kaplan, Robert ^a   Manson, Joann E ^b   Rajkovic, Aleksandar ^c   Connelly, Stephanie A ^d   MacKey, Rachel H ^e   Tinker, Lesley F ^f   Curb, J David ^g   Eaton, Charles B ^h   Wassertheil Smoller, Sylvia ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF HAWAII   (United States)

^h BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; BODY SIZE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; POSTMENOPAUSE;

ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH BEHAVIOR; HUMANS; INFLAMMATION MEDIATORS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; POSTMENOPAUSE; RISK FACTORS; UNITED STATES;

EID: 79959637527     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.332     Document Type: Article

References (25)

1. Wildman RP, Muntner P, Reynolds K et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168: 1617-1624.
2. Wildman RP, Lin J, Muntner P et al. Risk of incident coronary heart disease and stroke associated with abdominal obesity versus the metabolic syndrome and diabetes. Obesity, in press.
3. Kip KE, Marroquin OC, Kelley DE et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004;109:706-713. (Pubitemid 38222888)
4. Song Y, Manson JE, Meigs JB et al. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007;100:1654-1658. (Pubitemid 350130235)
5. Flint AJ, Hu FB, Glynn RJ et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) 2010;18:377-383.
6. Arnlöv J, Ingelsson E, Sundström J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010;121:230-236.
7. Weyer C, Yudkin JS, Stehouwer CD et al. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002;161:233-242. (Pubitemid 34214841)
8. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978. (Pubitemid 29177345)
9. Festa A, D'Agostino R Jr, Williams K et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001;25:1407-1415. (Pubitemid 32977855)
10. Desai MY, Dalal D, Santos RD et al. Association of body mass index, metabolic syndrome, and leukocyte count. Am J Cardiol 2006;97:835-838.
11. Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K. Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men. Cardiovasc Diabetol 2007;6:27.
12. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring) 2006;14:2127-2131. (Pubitemid 46121966)
13. Hays J, Hunt JR, Hubbell FA et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003;13:S18-S77. (Pubitemid 37324176)
14. Langer RD, White E, Lewis CE et al. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003;13:S107-S121. (Pubitemid 37324180)
15. Kaplan RC, McGinn AP, Baird AE et al. Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study. J Stroke Cerebrovasc Dis 2008;17:344-355.
16. Wassertheil-Smoller S, Kooperberg C, McGinn AP et al. Lipoproteinassociated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women. Hypertension 2008;51:1115-1122. (Pubitemid 351398957)
17. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 2005;183:308-315. (Pubitemid 41579282)
18. Blüher M, Fasshauer M, Tönjes A et al. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 2005;113:534-537. (Pubitemid 41585991)
19. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005;69:29-35. (Pubitemid 40813409)
20. Han TS, Sattar N, Williams K et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002;25:2016-2021. (Pubitemid 41071061)
21. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004;110:380-385. (Pubitemid 38993845)
22. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003;168:351-358. (Pubitemid 36703335)
23. Malavazos AE, Corsi MM, Ermetici F et al. Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 2007;17:294-302. (Pubitemid 46551684)
24. Stefan N, Kantartzis K, Machann J et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168: 1609-1616.
25. Karelis AD, Faraj M, Bastard JP et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150. (Pubitemid 41058189)